Skip to main content
. 2019 Oct 3;14(10):e0222948. doi: 10.1371/journal.pone.0222948

Table 4. Differential gene expression in PostR biopsies of patients with FSGS partially correlates with local TNF expression and with clinical parameters.

Gene Symbol Gene ID TNF DFPE DFPW UPCR eGFR
TNF 7124
CCL2 6347
CCL20 6364
CCL3 6348
CEBPD 1052
CXCL1 2919
CXCL2 2920
IL1B 3553
MAP3K8 1326
NFKBIZ 64332
PIM2 11040
SOD2 6648
CSF3 1440

Red boxes—positive correlation, green boxes—negative correlation, grey boxes—no significant correlation.

DFPE = difference in foot process effacement measured in PreR and PostR biopsies; DFPW = difference in foot process width measured in PreR and PostR biopsies; UPCR = urinary protein-to-creatinine ratio, eGFR = estimated glomerular filtration rate. TNF—tumor necrosis factor, CCL2—C-C Motif Chemokine Ligand 2, CCL20—C-C Motif Chemokine Ligand 20, CCL3—C-C Motif Chemokine Ligand 3, CEBPD—CCAAT/Enhancer Binding Protein Delta, CXCL1—chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha), CXCL2—chemokine (C-X-C motif) ligand 2, IL1B—interleukin 1, beta, MAP3K8—Mitogen-Activated Protein Kinase Kinase Kinase 8, NFKBIZ—NFKB Inhibitor Zeta, PIM2—Pim-2 Proto-Oncogene, Serine/Threonine Kinase, SOD2—Superoxide Dismutase 2, CSF3—Colony Stimulating Factor 3.